SCHEMBL25868983

SCHEMBL25868983

CNCCCNC(c1ccccc1)(c1ccccc1)c1ccc(OC)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
KMT2A Q03164 1/20 0.47
KIF11 P52732 6/20 0.47
KCNH2 Q12809 1/20 0.47
HTR1B P28222 1/20 0.44
KCNN4 O15554 2/20 0.43
LTA4H P09960 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
DUT P33316 1/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409776 0.86 KCNN4 (0.49) HTTKIF11KCNH2KCNN4LTA4H
SCHEMBL9439820 0.85 KIF11 (0.47) HTTKDM4EMEN1KMT2AKIF11
SCHEMBL5391076 0.85 KIF11 (0.61) KIF11KCNH2KCNN4DRD2DRD4
SCHEMBL4363002 0.83 KIF11 (0.49) HTTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL12225852 0.83 KIF11 (0.49) HTTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL10071078 0.83 KIF11 (0.49) HTTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL6302955 0.82 KIF11 (0.45) HTTKDM4EMEN1KMT2AKIF11
SCHEMBL8053146 0.82 KIF11 (0.45) HTTKDM4EMEN1KMT2AKIF11
SCHEMBL8040236 0.82 KIF11 (0.44) HTTKIF11KCNH2KCNN4LTA4H
SCHEMBL10309879 0.82 KIF11 (0.45) HTTKDM4EMEN1KMT2AKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2906246-B1 VEGF NEUTRALIZING PRODRUGS COMPRISING RANIBIZUMAB FOR THE TREATMENT OF OCULAR CONDITIONS CHARACTERIZED BY OCULAR NEOVASCULARIZATION ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S (DK) 2023-07-26 EP disclosed